ABSTRACT Objective: Largely, watchful waiting is the initial policy for patients with small-sized or medium-sized vestibular schwannoma, because of slow growth and relatively minor complaints, that do not improve by an intervention. If intervention (microsurgery, radiosurgery or fractionated radiotherapy) becomes necessary, the choice of intervention appears to be driven by the patient's or clinician's preference rather than by evidence based. This study addresses the existing evidence based on controlled studies of these interventions.
INTRODUCTION
Vestibular schwannoma, also called acoustic neuroma, is not an uncommon benign brain tumour. It accounts for about 6% of all intracranial tumours. 1 A reliable register is available in Denmark, since almost all patients with a vestibular schwannoma are referred to one specialist clinic. The incidence approaches 20 per million per year. 2 Owing to its benign nature the prevalence accumulates to 200 per million. 3 The tumour originates from the Schwann cells of the vestibular section of the vestibulocochlear nerve at the borders of the central and peripheral myelin, usually slightly lateral to the rim of the internal auditory meatus. A vestibular schwannoma visualises characteristically at MRI (figure 1). In combination with symptoms like asymmetric hearing loss, tinnitus, vertigo or imbalance, the diagnosis is accepted without histological 
Key messages
▪ The literature search yielded cohort studies comparing microsurgery and radiosurgery. ▪ Quality assessment showed four studies likely to give unbiased results. ▪ Radiosurgery consistently emerges as the best practice for tumours smaller than 30 mm in cisternal diameter.
Strengths and limitations of this study
▪ All eligible studies compared the same interventions: microsurgical excision and radiosurgery. ▪ All four trustworthy controlled studies pointed to the same intervention as the best practice. ▪ Patients' outcomes in the assessed comparative studies are in accordance with long-term outcomes in sizeable contemporary case-series. ▪ The conclusion is limited to solitary vestibular schwannomas smaller than 30 mm.
verification. The majority grows slowly or not at all; the average growth is 1-2 mm/year. 4 5 However, if the tumour grows, the rate in the first year is on an average 5-10 mm. 6 There are no parameters known that predict which tumour will grow and to what extent. 7 8 The mild natural course and relatively minor symptoms-that do not improve by any intervention-justifies for small-sized and medium-sized tumours an initial policy of watchful waiting by sequential MRI follow-up. However, if the tumour is sizeable and obliterates the cistern of the cerebellopontine angle (CPA) or grows substantially during the follow-up, in principal, an intervention is indicated. In most centres, the choice is between microsurgical resection for any tumour size and radiosurgery for small-sized and medium-sized tumours or stereotactic radiotherapy for tumours over 25-30 mm diameter. Numerous case series and non-systematic reviews have been summarised recently by Arthurs et al. 4 Understandably, owing to inherent limitations of case series, these reviewers did not arrive at firm conclusions.
In this study, we limit our search for the best practice to comparative, controlled trials on interventions for vestibular schwannoma in a systematic and qualitative way.
METHODS

PubMed and Embase were searched in November 2011
for controlled intervention studies on vestibular schwannomas. We imposed no restrictions on the kind of intervention or patient characteristics. We performed Boolean searches using the following keywords ('vestibular schwannoma' OR 'acoustic neuroma' NOT neurofibromatoses) and (management OR therapy OR treatment OR intervention) and ('controlled trial' OR 'controlled study' OR 'clinical trial') or (comparative OR comparison OR compared) (see online supplementary appendix 1). No language, publication status or other search restriction was imposed. The retrieved articles were screened by title and if necessary by abstract. Eventually 13 full text articles were examined. The reference lists of studies meeting the eligibility criteria were checked. We also searched the Cochrane Central Register of Controlled Trials without finding further studies. The six eligibility criteria included controlled, intervention study on a newly diagnosed, solitary vestibular schwannoma reporting on clinical outcome.
The two neurosurgeons of our team appraised the articles for inclusion and assessed the risk of bias in the individual studies. The quality was assessed by judging criteria that were considered relevant by the team. The assessment is based on the Sign-50 quality criteria for cohort studies. (Our criteria are enlisted in 9 We abstracted the primary clinical outcome data: mortality, treatment failure (that is second intervention necessary), function of cranial nerves 7 and 8, other intervention-associated complications and the data on quality of life. These outcome measures are the most important to the patient. Secondary outcome measures, being duration of hospital stay and time off work were also addressed. Table 1 on risk of bias and table 3 on outcome measures served as a predefined format for data extraction. Disagreements between the two reviewers were resolved by consensus.
RESULTS
No randomised clinical trials on solitary vestibular schwannoma were found. Only two studies-both comparing microsurgical excision with radiosurgeryshowed up that had a controlled, prospective design with predefined inclusion criteria. 10 11 The search retrieved another four retrospective cohort studies with a matched control group, all comparing again microsurgery and radiosurgery. [12] [13] [14] [15] We identified no controlled studies involving fractionated stereotactic radiotherapy (figure 2). Four main quality items were assessed: selection of subjects, outcome measure, known confounders and statistical analysis (table 1) . At the inception, in five out of six studies all patients were at the same stage of the disease having minor symptoms, tumour size limited to 30 mm extension into the CPA and no earlier intervention. ne exception is the study of Karpinos et al, 13 which included recurrent tumours. The indication for an intervention was clearly defined in only one study. 11 In the other studies, just having a vestibular schwannoma seemed sufficient to initiate an intervention, be it excision or radiosurgery. Baseline patient characteristics were quite similar in the treatment arms within the studies (table 2) . Only the average age was higher in all radiosurgery arms. Specific allocation to the radiosurgery arm because of comorbidity or high age was permitted in all but the study of Pollock et al. 10 These are known hazards for a favourable outcome. If imbalance was present, the higher risk patients were in the radiosurgery arms. There was minimal or no loss to follow-up in all but one study. 13 After summation of the number of items that downgrade the confidence in outcome (bold No in table 1), four studies remained that showed trustworthy association between interventions and outcomes. 10-12 15 The outcomes are specified in table 3. There was 1% mortality in two microsurgery arms. 14 15 After radiosurgery, there was no mortality and no surgical or anaesthetic complications, but better facial function, better hearing preservation and better quality of life.
DISCUSSION
Microsurgery and radiosurgery are equally effective interventions for vestibular schwannomas as demonstrated by numerous case series that were recently reviewed. 4 While taking into account patients' individual preferences, ideally the choice of treatment should be based on high-quality evidence from well-conducted clinical trials. We found evidence of greater clinical effectiveness of radiosurgery compared with that of microsurgery in medium-sized tumours.
Systematic reviews of randomised clinical trials-preferably double-blinded-are considered the gold standard of evidence-based practice. Regarding vestibular schwannomas, however, we most probably will have to do without randomised studies. Indeed, Myrseth et al 11 failed to go on with their randomised trials, because patients were reluctant to accept chance to decide whether they would undergo surgery or radiosurgery.
11
Next best evidence is obtained from well-designed nonrandomised controlled trials. 16 17 Next to the value of well-conducted randomised trials, the value of highquality observational studies is validated by the remarkable similar results, which were observed when comparing specific treatments through both randomised and observational trials. [18] [19] [20] Such observational studies may provide trustworthy information on the risks of the intervention, on adverse events and ultimately on the quality of life of patients. Overall, these patients are more No: poorly or not addressed or not reported; cause for bias. Bold: possible relevant bias, decreasing confidence. ++, All or most of the criteria have been fulfilled. Where they have not been fulfilled the conclusions of the study or reviews are thought to be very unlikely to alter. +, Some of the criteria have been fulfilled. Those criteria that have not been fulfilled or not adequately described are thought unlikely to alter the conclusions. −, Few or no criteria fulfilled. The conclusions of the study are thought likely or very likely to alter.
similar to the general disease population than those complying with the strict inclusion and exclusion criteria of a randomised clinical trial. Such high quality of observational studies is achieved by studying the same intervention by the same outcome measures in well-matched patient population without dropouts. Based on Sign-50, this is the basic thought behind the assessment of quality of individual studies in table 1.
Selection of subjects
All retrieved controlled studies compared the same two interventions and consistently pointed to radiosurgery as being the best intervention for their research question. Some studies, however, provide more confidence to have unbiased results, as elucidated in table 1. A major risk of bias of all observational studies is that the compared groups are substantially unequal in their initial susceptibility to the outcome. In five studies the selection bias is reasonably controlled, since the compared groups are very similar except for the interventions under study. Only in the study by Karpinos et al 13 the source population differed due to inclusion of patients having had earlier surgery for the same disease. In addition, this study had an unacceptably high loss to follow-up of over 20%. These two serious sources of bias prevented a favourable overall good quality judgement. In one study pertinent bias arose, because of non-consecutive inclusion in the microsurgery arm. 14 
Only Myrseth et al
11 clearly defined the starting point of an intervention. Nevertheless, confounding by indication between the various studies appears unlikely, since major adverse events, like disabling neurological deficits, do not occur in the natural history of vestibular schwannomas smaller than 30 mm. It is very implausible that any of the major adverse events occur in the absence of an intervention. Therefore, the risk that an adverse outcome occurs by chance instead of being related to the intervention is not realistic and we assigned no relevance to the potential confounder of being at various points in the disease progression (non-bold No, table 1).
Outcome assessment
All but one study reported on the same clinical outcome measures, which are: failure because a second intervention was needed, function preservation of the involved cranial nerves, more general complications and quality of life. The exception is the study by Karpinos et al, who did not report on quality of life. All used established classifications of facial motor function and useful hearing.
Only one group managed a blinded outcome measurement. 10 Taking into account that a troublesome outcome-when occurring-is quite clear-cut in this disease, non-blinded outcome measurement did not depreciate our trust that the reported outcome is true and caused by the specific intervention. Typically, repeated measurements increase this trust further.
Confounding variables
A previous treatment for the same disease induces relevant bias, because of different baseline characteristics and an inherent higher risk for adverse events. As mentioned already, this applied to the study of Karpinos et al, 13 because the results from first and second interventions were not separated in their report. Frail patients were in all but the study of Pollock et al 10 inclined to end up in the radiosurgery arm. In general higher age, comorbidity and larger tumours are drawbacks for a good outcome. In those studies showing significant imbalance of these variables the potential disadvantage, however, was at the side of radiosurgery, which nevertheless produced the best outcome in all studies. 12 13 15 As these imbalances work in favour of microsurgery, we considered them not relevant (non-bold Nos in table 1).
The overall assessment of study quality gave confidence in four studies, because no relevant biases were identified. Quite importantly, all four consistently showed a significant advantage for radiosurgery over microsurgical excision, when directly compared in a controlled manner (table 2) .
One might argue that a weakness of some of the four trustworthy studies is the relative small numbers and short follow-up. However, patients' outcome in the assessed comparative studies is in accordance with the long-term outcome in sizeable contemporary radiosurgery series as summarised in online supplementary appendix 2. [21] [22] [23] [24] [25] Radiosurgery for vestibular schwannoma is a day case with 2% (median) of patients requiring additional treatment; less than 1% (median) experienced some facial neuropathy and trigeminal neuropathy occurred in 5% (median). It has no direct mortality and the risk of incapacitating complications is negligible or non-existing. The comprehensive review of Arthurs et al showed that after microsurgery less than 2% of patients required additional treatment. The rates of facial nerve palsy are as high as 10-30%, varying with tumour size. 4 These numbers are of the same range in the comparative studies on tumours limited to a size of 3 cm in table 2. Not mentioned in any detail by Arthurs et al are other surgical morbidities, which are not trivial at all, being between 14% and 47% in the comparative studies. Major adverse events like mortality and discharge to long-term care may occur after microsurgery in about 0.5% and 1.2%, respectively. 26 Not addressed in the comparative studies is the risk of secondary cancer after radiation for a benign tumour causing mortality. Indeed, radiation-associated tumours do occur after sufficient follow-up of 5-20 years. So far, 12 cases of radiosurgery-associated malignant tumours have been reported worldwide. 27 Based on model calculations the probability of a malignant tumour after radiosurgery is estimated at 1 per 1000. 28 Distinctively, the hospital-based study mentioned herein before depicted 2643 surgeries in 265 US hospitals for vestibular schwannoma and showed a 3-month mortality of 0.5%. 26 If radiosurgery is not employed too enthusiastically owing to its low threshold, but on proper indication, the risk of death by a radiation-induced tumour is not relevant in comparison to the (few) possible direct disasters of microsurgery. Undeniably, the mortality is much smaller and, if it occurs, it may do so many years later in a patient's life.
Looking for the best practice, one should realise indeed that the results of various health-related quality-of-life studies after surgery called for modesty. Deterioration of the well-being of the patient proved difficult to avoid, even in elective surgery of relatively small tumours. [29] [30] [31] In addition, the comparative studies showed deterioration in the quality of life as high as in 30-45% of patients operated on (table 3) . Once an intervention is considered necessary, we conclude based on this systematic review of controlled studies, that radiosurgery is the best practice for patients with solitary vestibular schwannoma up to 30 mm in cisternal extension.
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